Adipocyte metabolism modulation

Adipocyte metabolism modulation" is not a single molecule or receptor but rather refers to the broad biological process of altering the metabolic activity of adipocytes—cells specialized in storing fat and regulating energy homeostasis. This process encompasses multiple molecular targets and signaling pathways that control lipid storage, glucose uptake, thermogenesis, and secretion of bioactive molecules known as adipokines. Key regulators include transcription factors such as PPARγ and C/EBPα for adipogenesis; signaling proteins like AMP-activated protein kinase (AMPK) for energy sensing; hormones such as leptin and adiponectin that influence systemic metabolism through their respective receptors; and inflammatory cytokines like TNF-alpha that can impair insulin sensitivity[1][2][3][6]. Drugs targeting these individual components—such as thiazolidinediones acting on PPARγ or metformin activating AMPK—are used to treat metabolic diseases including obesity and type 2 diabetes[2]. Because "adipocyte metabolism modulation" is a functional concept rather than a discrete therapeutic target or molecule, it cannot be classified with a canonical name or abbreviation. For structured data purposes, it should be mapped instead to its constituent molecular targets such as "Peroxisome proliferator–activated receptor gamma," "AMP–activated protein kinase," "Leptin receptor," etc.[1][2]. There is something incorrect about using "Adipocyte metabolism modulation" as a therapeutic target entry because it describes an entire physiological process involving many different proteins/receptors/enzymes rather than one specific druggable entity. For structured databases focused on drug discovery or pharmacology, this entry should be replaced by more precise molecular targets within the pathway.